CO-197 Denial Code: Why 9 in 10 Practices Never Fight It.
Most CO-197 denials get written off without a second look. The authorization was missing, the claim denied, the balance gets absorbed, and the team moves on to the next claim in the queue. That instinct is understandable given how common this denial is, but it’s also, according to the best available national data, usually the wrong call.
What CO-197 Actually Means
CARC 197 is officially defined as “Precertification/authorization/notification/pre-treatment absent.” The CO group code in front of it means Contractual Obligation, so the provider is expected to have obtained the required approval before the service, and the balance generally cannot be shifted to the patient. This is a utilization management denial specifically, it addresses whether permission to perform the service existed, not whether the service was medically necessary or correctly coded, and that distinction shapes how it should be fixed.
The payer’s system checks for an authorization tied to the specific claim and either finds nothing, or finds something that doesn’t line up with what was actually billed.
The Number That Should Change How You Handle This Code
Here’s what national data on prior authorization actually shows. According to KFF’s analysis of 2024 CMS reporting, Medicare Advantage insurers made nearly 53 million prior authorization determinations that year and fully or partially denied 4.1 million of them, a 7.7% denial rate. Of those denied requests, only 11.5% were ever appealed. But among the appeals that were filed, 80.7% were fully or partially overturned.
Read that again from the other direction: roughly 9 out of 10 denied prior authorization requests were never challenged at all, and the ones that were challenged succeeded more than 8 times out of 10. That’s not a marginal case for appealing. That’s a strong signal that the default behavior, writing off a CO-197 without pushing back, is leaving a substantial amount of legitimately recoverable revenue on the table across the industry.
Overturn rates vary meaningfully by insurer within that data. KFF’s broader analysis found appeal success rates ranging from around 40% at the low end to over 90% at the high end depending on the specific plan, so results aren’t uniform across every payer. But even the more conservative end of that range makes a real case for appealing rather than defaulting to a write-off, especially for a denial type that doesn’t require proving medical necessity from scratch, only that the authorization process itself should have gone differently.
Common Reasons Behind a CO-197
- No authorization request was ever submitted. The service was scheduled, performed, and billed without anyone realizing this specific payer required advance approval for it.
- The request was submitted but not completed before the service date. The clock ran out on scheduling versus approval turnaround time.
- Notification requirements were missed. Some payers require notification rather than full authorization for certain services, and the two get confused internally, leading to the wrong step being skipped.
- Authorization expired before the service was rendered. The approval had a defined window and the actual visit or procedure fell outside it.
- Site-of-service mismatch. An authorization obtained for one place of service, say an outpatient hospital department, does not automatically extend to the same procedure performed at a different site, such as an ambulatory surgical center or a different facility entirely, even for the identical CPT code and patient. This is a specific, frequently overlooked trigger that has nothing to do with whether authorization was sought at all, only where the service ultimately happened.
CO-197 Versus CO-198: A Distinction Worth Getting Right
CO-197 and CO-198 both relate to authorization, but they describe fundamentally different situations, and confusing them sends the appeal effort in the wrong direction.
CO-197 means no authorization exists for the service at all. The request was never made, or was made and never completed.
CO-198 means an authorization does exist, but it’s been exceeded or doesn’t match what was billed, too many units, the wrong date range, or a different scope than what the claim reflects.
The recovery path differs accordingly. A CO-197 typically requires either a retroactive authorization request or a full appeal arguing the service should be covered despite the missed step. A CO-198 is usually a scope problem, and the fix is demonstrating that the billed service falls within, or should be reconciled against, the existing approval, which is a narrower and often faster argument than rebuilding a case from zero. Treating a CO-198 like a CO-197, starting an appeal from scratch instead of pointing to the authorization that already exists, wastes time arguing a point that isn’t actually in dispute.
PR-197: The Same Missing Step, Different Financial Outcome
As with the other paired codes in this series, the same reason code can appear with a different group code and a different financial result. PR-197 shifts the balance to the patient rather than the provider. This is less common than CO-197 for standard commercial and Medicare Advantage claims, since most payer contracts assign the authorization burden to the provider, but it can appear depending on specific plan terms or out-of-network circumstances where the patient bears more direct responsibility for confirming coverage requirements before receiving care.
How to Work a CO-197 Denial
- Determine which situation actually applies. No authorization at all, an authorization that expired, or an authorization that exists but doesn’t match the site of service or scope billed. Each points to a different fix.
- Check whether retroactive authorization is available. Many payers allow a retro-auth request for a limited window after the service, particularly when the omission was an administrative error rather than a denial of medical necessity itself.
- If retro-authorization isn’t available, build the appeal around medical necessity and the circumstances of the omission, not just an apology for the missed step. Clinical documentation showing the service was appropriate strengthens the case considerably.
- File within the payer’s appeal window. These windows vary and are frequently measured in a specific number of days from the denial date, so treat the deadline as fixed rather than flexible.
- Don’t skip the appeal by default. Given that a large majority of denied prior authorization requests are never appealed nationally, and that appealed requests succeed at a high rate, defaulting to a write-off without at least assessing the appeal case is very likely costing more than the effort to pursue it would.
- Track the specific trigger by payer. If site-of-service mismatches or expired authorization windows keep recurring with one particular payer, that’s a scheduling and verification process fix, not a one-off appeal issue.
Why Overturn Rates Vary So Much by Insurer
The 80.7% aggregate overturn figure hides a wide spread underneath it, and that spread is worth knowing before deciding how much confidence to put into any single appeal. Among the major Medicare Advantage insurers KFF tracked in its detailed 2024 breakdown, overturn rates on appeal ranged from around 40% at the lower end to more than 90% at the higher end, depending on which specific insurer issued the original denial.
That range matters practically. A practice dealing primarily with a plan sitting at the higher end of that range has a strong statistical case for appealing nearly every CO-197 that looks even plausibly winnable. A practice facing a plan at the lower end still has a better-than-coin-flip case, but the calculus around how much staff time to invest per appeal shifts accordingly. Tracking overturn outcomes by specific payer, rather than treating “appeal or don’t” as a single blanket policy across every plan a practice bills, lets a billing team calibrate effort to the actual odds for that specific insurer rather than guessing.
KFF’s analysis also noted that a high overturn rate cuts two ways as a signal. It can mean an initial denial process is too aggressive relative to what actually gets approved on closer review, or it can mean the original submission was frequently missing something correctable, like a specific piece of documentation, that gets supplied at the appeal stage. Either interpretation supports the same practical conclusion: a denial alone doesn’t tell you whether the service should have been approved, and finding out generally requires actually filing the appeal rather than assuming the first answer was final.
Specialty Patterns Worth Watching
CO-197 doesn’t distribute evenly across specialties, and where it concentrates changes what prevention should look like.
Imaging and advanced diagnostics carry some of the heaviest prior authorization burden of any category, particularly for MRI, CT, and certain nuclear medicine studies, and scheduling turnaround time is frequently tighter than typical authorization processing time, making expired or missing authorizations a recurring pattern rather than an occasional miss.
Surgical specialties see CO-197 concentrated around site-of-service questions specifically, since many procedures can legitimately be performed in more than one setting, a hospital outpatient department, an ambulatory surgical center, or occasionally an office setting, and payers increasingly require the authorization to specify which.
Behavioral health and physical therapy tend to see CO-197 tied to visit-count authorizations running out mid-course of treatment, where an initial approval covered a defined number of sessions and treatment continued past that count before a renewal authorization was requested.
Knowing which pattern applies to a given practice’s specialty mix focuses the prevention effort on the actual recurring failure point rather than a generic “get better at authorizations” instruction that doesn’t target where the real gap is.
What a Strong CO-197 Appeal Actually Includes
A high overturn rate doesn’t happen by accident. The appeals that succeed tend to share a common structure rather than relying on general persistence.
The strongest submissions open by identifying the specific claim, date of service, and denial code, then state plainly whether the argument is a retroactive authorization request or a full appeal contesting the denial. From there, the documentation does the actual work: clinical notes establishing that the service met medical necessity criteria independent of the authorization question, any evidence that an authorization request was in fact submitted but processed late or lost on the payer’s end, and, where relevant, proof that the service was urgent enough that delaying it for authorization to clear would have been clinically inappropriate.
Vague appeals that simply state the denial should be reconsidered without new information attached rarely move a payer. Appeals that supply something the original submission lacked, a missing clinical note, a corrected authorization request, documentation of medical urgency, give the reviewer a concrete reason to reach a different conclusion the second time. This is also consistent with KFF’s observation that high overturn rates can partly reflect original submissions that were missing something correctable rather than services that should never have been approved.
Filing promptly matters as much as filing well. Appeal windows are typically measured in a fixed number of days from the denial date, and a strong case submitted after the deadline has already lost regardless of its merits.
Preventing CO-197 Before It Happens
The most reliable prevention is verifying authorization requirements at scheduling, not at check-in the day of service, since authorization turnaround time needs to be built into the scheduling window itself rather than discovered as a deadline already at risk. Confirming the specific site of service matches what any existing authorization covers, particularly for procedures that could plausibly happen at more than one location, closes one of the more overlooked gaps on the list above. For high-authorization-volume specialties, a standing tracking log noting authorization numbers, approved date ranges, and approved sites of service against the actual scheduled appointment catches mismatches before the claim goes out rather than after it comes back denied.
What does CO-197 denial code mean?
It means the payer required precertification, authorization, or notification before the service, and that requirement wasn't met. The CO group code means the provider absorbs the cost and cannot bill the patient.
Should I always appeal a CO-197 denial?
It's worth assessing every time rather than defaulting to a write-off. National data from KFF shows that among Medicare Advantage prior authorization denials, only 11.5% were appealed in 2024, but 80.7% of those appeals were fully or partially overturned.
What's the difference between CO-197 and CO-198?
CO-197 means no authorization exists for the service at all. CO-198 means an authorization exists but has been exceeded or doesn't match what was billed, such as the wrong unit count or date range.
